Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKD 18.04

(0.33%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 78.58 Billion 74.66 Billion 66.11 Billion 59.76 Billion 56.89 Billion 51.48 Billion
Total Current Assets 55.98 Billion 57.06 Billion 52.81 Billion 47.39 Billion 45.98 Billion 43.03 Billion
Cash And Short Term Investments 21.31 Billion 22.55 Billion 22.37 Billion 19.47 Billion 18.46 Billion 16.11 Billion
Cash and Cash Equivalents 21.3 Billion 22.49 Billion 22.37 Billion 19.47 Billion 18.46 Billion 16.11 Billion
Short Term Investments 4 Million 56.87 Million -349.25 Million 4 Million -337.48 Million -322.39 Million
Net Receivables 21.29 Billion 20.92 Billion 19.16 Billion 17.48 Billion 17.44 Billion 15.54 Billion
Inventory 11.5 Billion 10.67 Billion 10.43 Billion 9.76 Billion 9.49 Billion 9.23 Billion
Other Current Assets 1.86 Billion 2.91 Billion 827.45 Million 670.11 Million 578.84 Million 2.13 Billion
Total Non-Current Assets 22.6 Billion 17.6 Billion 13.3 Billion 12.36 Billion 10.91 Billion 8.45 Billion
Net PPE 7.51 Billion 6.56 Billion 5.68 Billion 5.09 Billion 4.43 Billion 3.64 Billion
Good Will And Intangible Assets 4.02 Billion 3.65 Billion 3.42 Billion 3.27 Billion 3.31 Billion 1.83 Billion
Good Will 829.47 Million 829.47 Million 829.47 Million 825.57 Million 825.57 Million 825.57 Million
Intangible Assets 3.19 Billion 2.82 Billion 2.59 Billion 2.45 Billion 2.48 Billion 1.01 Billion
Long-Term Investments 9.44 Billion 5.84 Billion 3.24 Billion 2.74 Billion 2.28 Billion 2.39 Billion
Tax Assets 1.16 Billion 865.33 Million 794.23 Million 751.72 Million 594.99 Million 569.14 Million
Other Non Current Assets 452.2 Million 672.66 Million 168.48 Million 490.89 Million 289.53 Million 2.58 Million
Other Assets - - - 1.00 1.00 -
Total Liabilities 41.9 Billion 41.02 Billion 34.79 Billion 31.55 Billion 30.9 Billion 28.33 Billion
Total Current Liabilities 36.23 Billion 37.39 Billion 32.25 Billion 29.24 Billion 29.37 Billion 26.94 Billion
Account Payables 15.68 Billion 14.96 Billion 14.73 Billion 14.15 Billion 13.68 Billion 11.96 Billion
Tax Payables 386.55 Million 375.71 Million 233.49 Million 316.1 Million 248.01 Million 963.54 Million
Short Term Debt 8.04 Billion 9.24 Billion 8.67 Billion 8.5 Billion 6.09 Billion 6.1 Billion
Deferred Revenue 11.8 Billion 1.00 8.5 Billion 6.42 Billion 8.99 Billion 963.54 Million
Other Current Liabilities 695.88 Million 13.18 Billion 346.06 Million 155.97 Million 606.81 Million 7.9 Billion
Total Non Current Liabilities 5.67 Billion 3.63 Billion 2.53 Billion 2.31 Billion 1.52 Billion 1.38 Billion
Long-Term Debt 3.9 Billion 2.18 Billion 1.25 Billion 1.05 Billion 551.49 Million 413.55 Million
Deferred Revenue Non Current 1 Billion 930.92 Million 826.85 Million 784.07 Million 575.83 Million 490.42 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 130.89 Million 121.76 Million 128.17 Million 181.75 Million 132.96 Million 235.94 Million
Other Liabilities 1.00 - - - 1.00 1.00
Total Equity 36.67 Billion 33.63 Billion 31.32 Billion 28.2 Billion 25.98 Billion 23.14 Billion
Stock Holders Equity 34.91 Billion 32.06 Billion 29.06 Billion 26.14 Billion 24.18 Billion 21.68 Billion
Common Stock 1.62 Billion 1.62 Billion 1.62 Billion 1.62 Billion 1.62 Billion 1.62 Billion
Retained Earnings 20.95 Billion 18.26 Billion 15.58 Billion 12.93 Billion 11.16 Billion 8.82 Billion
Accumulated other comprehensive income -24.34 Million -12.9 Million -17.47 Million -17.67 Million -138.95 Thousand -2.98 Billion
Common Stock Equity 34.91 Billion 32.06 Billion 29.06 Billion 26.14 Billion 24.18 Billion 21.68 Billion
Capital Lease Obligation 578.19 Million 545.84 Million 497.69 Million 561.82 Million 546.99 Million -
Total Investments 9.45 Billion 5.89 Billion 2.89 Billion 2.75 Billion 1.94 Billion 2.07 Billion
Total Debt 11.95 Billion 11.42 Billion 9.92 Billion 9.56 Billion 6.64 Billion 6.52 Billion
Net Debt -9.35 Billion -11.06 Billion -12.45 Billion -9.9 Billion -11.81 Billion -9.59 Billion

Balance Sheet Charts